中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Structure-based drug design of a novel family of chalcones as PPARα agonists: virtual screening, synthesis, and biological activities in vitro1

文献类型:期刊论文

作者Xianghua LI; Hanjun ZOU; Anhui WU; Yangliang YE; Jianhua SHEN
刊名Acta Pharmacologica Sinica
出版日期2007
卷号28期号:12页码:2040
关键词peroxisome proliferator-activated receptors drug design virtual screening
ISSN号1671-4083
英文摘要Aim: To design and synthesize a novel class of peroxisome proliferator-activated receptors (PPAR)α agonists, which is obtained by the combination of the classical fibrate "head group", a linker with appropriate length and a chalcone. Methods: Thirty seven compounds were designed and identified employing the virtual screening approach. Six compounds were then selected for synthesis and bioassay according to the virtual screening results, structural similarity, and synthetic complexity. Results: Six new compounds (4b and 4d-h) were synthesized and bioassayed. All were found to be potent PPARα agonists, compound 4 h being the most prominent with a 50% effective concentration value of 0.06 μmol/L. Conclusion: This study provides a promising novel family of chalcones with a potential hypolipidemic effect.
语种英语
源URL[http://119.78.100.183/handle/2S10ELR8/293910]  
专题中国科学院上海药物研究所
作者单位中国科学院上海药物研究所
推荐引用方式
GB/T 7714
Xianghua LI,Hanjun ZOU,Anhui WU,et al. Structure-based drug design of a novel family of chalcones as PPARα agonists: virtual screening, synthesis, and biological activities in vitro1[J]. Acta Pharmacologica Sinica,2007,28(12):2040.
APA Xianghua LI,Hanjun ZOU,Anhui WU,Yangliang YE,&Jianhua SHEN.(2007).Structure-based drug design of a novel family of chalcones as PPARα agonists: virtual screening, synthesis, and biological activities in vitro1.Acta Pharmacologica Sinica,28(12),2040.
MLA Xianghua LI,et al."Structure-based drug design of a novel family of chalcones as PPARα agonists: virtual screening, synthesis, and biological activities in vitro1".Acta Pharmacologica Sinica 28.12(2007):2040.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。